Antiretroviral effect of a gag-RNase HI fusion gene

Gene Therapy

Volumn 4, Issue 6, 1997, Pages 593-599

  Schumann, G ^a   Cannon, K ^a   Ma, W P ^b   Crouch, R J ^b   Boeke, J D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Antiviral gene therapy; Murine leukemia virus; RCAS vectors; RNase HI; Serratia nuclease

Indexed keywords

ANTIRETROVIRUS AGENT; COAT PROTEIN; GAG PROTEIN; HYBRID PROTEIN; RIBONUCLEASE H;

ANTIVIRAL ACTIVITY; ARTICLE; ESCHERICHIA COLI; GENE FUSION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

ESCHERICHIA COLI; MURINAE; MURINE LEUKEMIA VIRUS; SERRATIA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; UNIDENTIFIED RETROVIRUS;

EID: 0030764480     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300421     Document Type: Article

References (29)

1. Natsoulis G, Boeke JD. New antiviral strategy using capsid-nuclease fusion proteins. Nature 1991; 352: 632-635.
2. Natsoulis G et al. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci USA 1995; 92: 364-368.
3. Schumann G et al. Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures. J Virol 1996; 70: 4329-4337.
4. Wu X et al. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol 1995; 69: 3389-3398.
5. Fletcher TM III et al. Virion associated accessory proteins, new targets for antiviral therapy. In: Girard M, Dodet B (eds). Retroviruses of Human AIDS and Related Animal Diseases. Dixieme Colloque des Cent Gardes-1995, 1995, pp 99-106.
6. Boeke JD, Hahn B. Destroying retroviruses from within. Trends Microbiol 1996; 4: 421-426.
7. Perelson AS et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1582-1586.
8. Wei X et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.
9. Tucker PW, Hazen EE, Cotton FA. Staphylococcal nuclease reviewed: a protorypic study in modern enzymology. Isolation; physical and enzymatic properties. Mol Cell Biochem 1978; 22: 67-77.
10. Altman PL. Blood and Other Body Fluids. Federation of American Societies for Experimental Biology: Washington, DC, 1961.
11. Ball TK, Suh Y, Benedik MJ. Disulfide bonds are required for Serratia marcescens nuclease activity. Nucleic Acids Res 1992; 20: 4971-4974.
12. Ma W-P, Crouch RJ. Escherichia coli RNAse HI inhibits murine leukaemia virus reverse transcription in vitro and yeast retrotransposon Ty1 transposition in vivo. Genes to Cells 1996; 1: 581-593.
13. Eaves GN, Jeffries CD. Isolation and properties of an extracellular nuclease of Serratia marcescens. J Bacteriol 1963; 85: 273-278
14. Hostomsky Z, Hostomska Z, Mathews DA. Ribonucleases H. In: Linn SM, Lloyd RS, Roberts RJ (eds). Nucleases, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1993, pp 341-376.
15. Champoux JJ. Roles of ribonuclease H in reverse transcription. In: Skalka A, Goff S (eds). Reverse Transcriptase. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1993, 103-118.
16. Hughes SH, Koste E. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology 1984; 136: 89-99.
17. Hughes SH, Greenhouse JJ, Petropoulos CJ, Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helperindependent retroviral vectors. J Virol 1987; 61: 3004-3012.
18. Salter DW et al. Transgenic chickens: insertion of retroviral genes into the chicken germ line. Virology 1987; 157: 236-240.
19. Greenhouse JJ, Petropoulos CJ, Crittenden LB, Hughes SH. Helper-independent retrovirus vectors with Rous-associated virus type O long terminal repeats. J Virol 1988; 62: 4809-4812.
20. Federspiel MJ, Crittenden LB, Hughes SH. Expression of reticuloendotheliosis virus envelope confers host resistance. Virology 1989; 173: 167-177.
21. Petropoulos CJ, Hughes SH. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. J Virol 1991; 65: 3728-3737.
22. Barsov X, Hughes S. Amphotropic derivatives of RCAS vector system. J Virol 1996; 70: 3922-3929.
23. Bassin RH, Tuttle N, Fischinger JR Rapid cell culture assay technique for murine leukaemia viruses. Nature 1971; 229: 564-566.
24. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992; 66: 4893-4900.
25. Lori F et al. Viral DNA carried by human immunodeficiency virus type 1 virions. J Virol 1992; 66: 5067-5074.
26. Zhang H, Dornadula G, Pomerantz RJ. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells. J Virol 1996; 70: 2809-2824.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature 1970; 227: 680-685.
28. Carl PL, Bloom L, Crouch RJ. Isolation and mapping of a mutation in Escherichia coli with altered levels of ribonuclease H. J Bacteriol 1980; 144: 28-35.
29. Kingston RE, Chen CA, Okayama H, Rose JK. Introduction of DNA into eukaryotic cells. In: Ausubel FM et al (eds). Current Protocols in Molecular Biology. John Wiley & Sons: New York, 1996, pp 9.1.4-9.1.6.